South Korea
This expansion is scheduled to launch in Kazakhstan, Colombia, and several other Latin American countries in 2024, marking a strategic move that ...
January 02, 2024 | News
The proceeds will fund its robust clinical programs and bolster TiumBio's financial position. Data read-outs from a Phase 2 trial of merigolix...
January 01, 2024 | News
Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI ...
December 21, 2023 | News
The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI. The clinical trial (NCT02783482) GC5107B was a prosp...
December 18, 2023 | News
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health...
December 15, 2023 | News
- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with tha...
November 27, 2023 | News
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...
November 27, 2023 | News
The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...
November 23, 2023 | News
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...
November 22, 2023 | News
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced an expansion of its services in the&nb...
November 17, 2023 | News
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...
November 16, 2023 | News
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has received U.S. Food and Dr...
November 15, 2023 | News
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...
November 13, 2023 | News
Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...
November 10, 2023 | News
Most Read
Bio Jobs
News
Editor Picks